Literature DB >> 10355587

Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapy.

D Coso, R Costello, R Cohen-Valensi, D Sainty, M Nezri, J A Gastaut, R Bouabdallah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10355587     DOI： 10.1023/a:1008397226387

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

Review 1.  A focused review of hematopoietic neoplasms occurring in the therapy-related setting.

Authors:  Liping Zhang; Sa A Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 2.  Achieving optimal outcomes in chronic lymphocytic leukaemia.

Authors:  T J Hamblin
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Outcome of therapy-related acute promyelocytic leukemia with or without arsenic trioxide as a component of frontline therapy.

Authors:  Farshid Dayyani; Hagop Kantarjian; Susan O'Brien; Sherry Pierce; Dan Jones; Stefan Faderl; Guillermo Garcia-Manero; Jorge Cortes; Farhad Ravandi
Journal:  Cancer       Date:  2010-08-27       Impact factor: 6.860

Review 4.  Therapy-related myeloid leukemia.

Authors:  Lucy A Godley; Richard A Larson
Journal:  Semin Oncol       Date:  2008-08       Impact factor: 4.929

5.  Translocation (6;15)(q12;q15): A Novel Mutation in a Patient with Therapy-Related Myelodysplastic Syndrome.

Authors:  Saba F Ali; Rebecca J Sonu; Denis M Dwyre; Brian A Jonas; Hooman H Rashidi
Journal:  Case Rep Hematol       Date:  2015-12-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.